Skip to main content
Clinical Trials/NCT02957825
NCT02957825
Terminated
Not Applicable

Surveillance of High-risk Early Postsurgical Patients for Real-time Detection of Complications Using Continuing Wireless Monitoring

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2 sites in 1 country747 target enrollmentFebruary 2, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Complication, Postoperative
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment
747
Locations
2
Primary Endpoint
Disability-free survival
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to test the hypothesis that continuous wireless monitoring on the postsurgical ward will improve patient outcome, measured as disability-free survival at three months after surgery. Further, the investigators hypothesize that this tight control regimen decreases length of hospital stay and treatment costs in patients with complications.

Detailed Description

Every year, approximately 1,500,000 surgical procedures are performed in The Netherlands alone. After major surgery, the complication rate is conservatively estimated at 25%, with a rate of 15% for major complications. In these patients, the most important problems are a failure to timely detect developing complications and a failure to adequately rescue those patients. Currently, measurement of vital signs and standardized assessment of patient wellbeing are routinely performed intermittently for every 8-12 hours, which may lead to a failure to detect of patients with complications. The aim of this study is to test the hypothesis that continuous wireless monitoring on the postsurgical ward will improve patient outcome, measured as disability-free survival at three months after surgery. Further, the investigators hypothesize that this tight control regimen decreases length of hospital stay and treatment costs in patients with complications. The investigators will carry out this study as an interventional, randomized (per surgical ward), prospective, clinical trial; participating wards will be included using a stepped-wedge design. Primary outcome is disability-free survival at three months after surgery.

Registry
clinicaltrials.gov
Start Date
February 2, 2018
End Date
August 31, 2021
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

B Preckel

Professor of Anesthesiology

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Eligibility Criteria

Inclusion Criteria

  • Adult patients undergoing acute or elective major or intermediate surgery
  • American Society of Anesthesiology (ASA) score of I to IV

Exclusion Criteria

  • Inability to give written and informed consent
  • Refusal to participate

Outcomes

Primary Outcomes

Disability-free survival

Time Frame: 3 months

Disability-free survival as measured by the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaire

Secondary Outcomes

  • Quality of life as measured by EuroQoL questionnaire(3 months)
  • 90 day mortality(90 days)
  • In-hospital mortality(within 30 days)
  • Comprehensive Complication Index score (CCI)(within 30 days or until hospital discharge, whatever comes first)
  • Disability-free survival(1 month)
  • Patient Health Status(3 months)
  • Length of hospital stay(within 30 days or until hospital discharge, whatever comes first)
  • 30 day mortality(30 days)
  • ICU admission(within 30 days or until hospital discharge, whatever comes first)
  • Total number of complications(within 30 days or until hospital discharge, whatever comes first)
  • Number of patients with one or more complications (also from the surgical discharge letter)(within 30 days or until hospital discharge, whatever comes first)

Study Sites (2)

Loading locations...

Similar Trials